PAVmed Inc..
PAVM.US | Manufacture of medical and dental instruments and supplies
PAVmed Inc. is a medical device company focused on developing and commercializing innovative products for unmet medical needs. The company's portfolio includes products in the areas of vascular access, tissue ablation, and advanced diagnostics. PAVmed's key products and technologies include the Carp...Show More
Better Health for All
30
PAVmed Inc. is a medical device company focused on developing innovative products for unmet medical needs, aiming to improve patient outcomes. Its subsidiary, Lucid Diagnostics, offers the EsoGuard Esophageal DNA test, which demonstrates high analytical accuracy (96%), 89% sensitivity, 100% specificity, and 100% precision for early detection of esophageal precancer and cancer.
1
The test also has a 100% negative predictive value for detecting precancer in asymptomatic patients, identifying a significant number of at-risk individuals.
2
The company has no reported products with negative health impacts. The EsoGuard test is explicitly designed as a preventative health measure for early disease detection.
3
Furthermore, an $8 million NIH R01 grant supports a larger, five-year multicenter clinical study to further validate these findings.
4
Fair Money & Economic Opportunity
0
No evidence available to assess PAVmed Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess PAVmed Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
Tier 1 suppliers are audited every 2 years.
1
The company maintains traceability for all suppliers from the component level to finished goods, utilizing barcode technology.
2
Honest & Fair Business
0
No evidence available to assess PAVmed Inc. on Honest & Fair Business.
Kind to Animals
-60
PAVmed's policy states that when animal testing is required, it utilizes Institutional Animal Care and Use Committees (IACUCs) that adhere to the Animal Welfare Act and NIH OLAW policies.
1
The company minimizes animal testing where possible by exploring alternative bench test models, but has completed extensive animal testing for DisappEAR ear tubes and used a porcine animal model for CarpX, performing 22 simulated procedures on two animals.
2
PAVmed designs tests to minimize the number of animals required.
3
The company licensed the DisappEAR ear tube technology from Tufts University and other academic institutions.
4
Less than 1% of PAVmed's R&D spending supports the development of non-animal methods.
No War, No Weapons
0
PAVmed Inc. is described as a medical device company developing products such as the CarpX device, PortIO device, and EsoCheck device, none of which are related to weapons or military applications.
1
No information was found regarding revenue from arms or defense contracts, dual-use technology, sales to embargoed regimes, peacebuilding investments, or any other military or conflict-related activities.
2
The company's core business, as described, does not involve any defense or arms-related activities, nor does it have exposure to controversial weapons.
3
Planet-Friendly Business
-40
PAVmed Inc. reported total Scope 1 and 2 emissions of 115.79 metric tons CO₂e in 2023, an increase from 97.62 metric tons CO₂e in 2022.
1
The company did not disclose its Scope 3 emissions.
2
In 2023, 35% of the company's operational energy consumption was sourced from renewables.
3
The waste diversion rate for 2023 was 62%.
4
The company had no regulatory actions, violations, fines, or compliance issues mentioned in 2023.
5
Respect for Cultures & Communities
0
PAVmed has implemented a quarterly diversity and inclusion training program, with 95% employee participation in 2023.
1
The company is committed to establishing an effective grievance mechanism, which includes a confidential third-party hotline for all grievances.
2
Safe & Smart Tech
0
Over 75% of employees participated in at least one training program in 2022.
1
The company states it will not sell, share, or distribute Personal Information to third parties without prior written consent, except as provided in its policy and in accordance with applicable laws and regulations.
2
Users can choose whether or not to provide Personal Information and can opt-out of receiving newsletters and emails.
3
The company collects only the Personal Information that users choose to provide.
4
Third-party service providers acting on behalf of the company are required to protect information and not use Personal Information other than for requested services.
5
The company respects privacy, including the protection of Personal Information, and states its activities must comply with HIPAA and other applicable privacy laws.
6
The board administers cybersecurity risk oversight through the audit committee, and a third-party vendor, CyberTeam, is responsible for identifying, assessing, and managing cybersecurity risks, reporting directly to the Chief Operating Officer and providing periodic updates to the board and executive leadership.
7
Third-party partners are generally required to notify the company of cybersecurity incidents that compromise information security.
8
The company is not aware of any current or past cybersecurity incidents that have materially affected or are likely to materially affect the company.
9
CyberTeam tracks risks and incidents until mitigation or full remediation, overseeing mitigation plans with risk owners.
10
Zero Waste & Sustainable Products
-40
PAVmed Inc. achieved a waste recycling rate of 62% in 2023.
1
The company reported no waste disposal violations in the past three years.
2
In 2023, Lucid Diagnostics, a subsidiary, generated 2513 lbs of biohazard waste, which was disposed of responsibly.
3
The company has implemented waste reduction initiatives, including a digital Quality Management System (QMS) to reduce paper consumption and the elimination of Ethylene Oxide (EtO) sterilization for over 10,000 EsoCheck devices annually, which removed over 11 kg of EtO.
4